TD Private Client Wealth’s West Pharmaceutical WST Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$679K	Sell	2,710 -972	-26%	-$242K	0.01%	429
2025 Q4	$1.01M	Sell	3,682 -633	-15%	-$173K	0.02%	361
2025 Q3	$1.13M	Sell	4,315 -783	-15%	-$190K	0.03%	336
2025 Q2	$1.12M	Sell	5,098 -92	-2%	-$19.7K	0.03%	335
2025 Q1	$1.16M	Buy	5,190 +648	+14%	+$179K	0.03%	316
2024 Q4	$1.49M	Buy	4,542 +305	+7%	+$96K	0.04%	281
2024 Q3	$1.27M	Sell	4,237 -137	-3%	-$42K	0.04%	329
2024 Q2	$1.44M	Buy	4,374 +790	+22%	+$279K	0.05%	295
2024 Q1	$1.42M	Sell	3,584 -64	-2%	-$23.7K	0.05%	297
2023 Q4	$1.28M	Sell	3,648 -40	-1%	-$14.2K	0.05%	300
2023 Q3	$1.38M	Sell	3,688 -202	-5%	-$78.1K	0.06%	269
2023 Q2	$1.49M	Sell	3,890 -235	-6%	-$84K	0.06%	269
2023 Q1	$1.43M	Sell	4,125 -46	-1%	-$13.4K	0.06%	272
2022 Q4	$982K	Buy	4,171 +118	+3%	+$28K	0.05%	326
2022 Q3	$997K	Sell	4,053 -120	-3%	-$36.6K	0.05%	311
2022 Q2	$1.26M	Sell	4,173 -643	-13%	-$209K	0.06%	283
2022 Q1	$1.98M	Sell	4,816 -328	-6%	-$128K	0.08%	238
2021 Q4	$2.41M	Buy	5,144 +295	+6%	+$127K	0.1%	206
2021 Q3	$2.06M	Sell	4,849 -575	-11%	-$242K	0.09%	228
2021 Q2	$1.95M	Sell	5,424 -385	-7%	-$127K	0.08%	241
2021 Q1	$1.64M	Buy	5,809 +484	+9%	+$139K	0.08%	259
2020 Q4	$1.51M	Buy	5,325 +280	+6%	+$78.6K	0.08%	255
2020 Q3	$1.39M	Buy	5,045 +604	+14%	+$160K	0.08%	247
2020 Q2	$1.01M	Buy	4,441 +1,465	+49%	+$288K	0.06%	279
2020 Q1	$453K	Buy	2,976 +202	+7%	+$31.1K	0.03%	333
2019 Q4	$417K	Buy	+2,774	New	+$404K	0.03%	373